Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|---|---|---|---|---|
| 1 | ||||
| Pruritus | Pruritus | 16.1% - 27.6% | x | |
| Skin disorder | Unspecified disorder of skin and subcutaneous tissue | 16.1% - 27.6% | x | |
| Hypotension | Hypotension | 2.19% - 6.71% | x | |
| Angiopathy | Angiopathy | 2.19% - 6.71% | x | |
| Mediastinal disorder | Mediastinal disorder | 0.813% - 10.7% | x | |
| Hypoxia | Hypoxemia | 0.813% - 10.7% | x | |
| Apnoea | Apnoea | x | ||
| Cough | Cough | x | ||
| Gastrointestinal disorder | Gastrointestinal disorder | x | ||
| Headache | Headache | x | ||
| Nausea | Nausea | x | ||
| Nervous system disorder | Nervous system disorder | x | ||
| Paraesthesia | Paraesthesia | x | ||
| Tingling sensation | x | |||
| Vomiting | Vomiting | x | ||
| Respiratory depression | Respiratory depression | x | ||
| Pulmonary function test decreased | Respiratory depression | x | ||
| Pain | Stinging | x | ||
| Ventricular tachycardia | Non-sustained ventricular tachycardia | x | ||
| Hepatic failure | Hepatic insufficiency | x | ||
| Procedural pain | Procedural pain | 0% - 2.01% | x | |
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Acute myeloid leukaemia | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |